Drug · ALS · ALS · Verified drug
Edaravone (Radicava) structure · mechanism
Edaravone (Radicava) 2D structure
- Role
- Drug
- Mechanism class
- ALS
- Parent scaffold
- Aminobenzothiazole core
- Indication
- ALS — functional decline slowing · FDA
- Structure source
- Catalog seed
- FDA / EMA
- FDA
- ClinicalTrials.gov
- edaravone ALS
- Regulatory status
- Approved · FDA · ClinicalTrials.gov · ClinicalTrials.gov
Hand-written analysis
Mechanism
에다라본은 라디칼 포착으로 산화스트레스를 줄인다는 ALS 주사·경구제입니다. 릴루졸과 기전 층이 다릅니다. 효과 크기는 완만합니다.
Medicinal chemistry
피라졸론 엔올입니다. 벤조티아졸(릴루졸)과 구조가 갈립니다.
Indication · context
ALS 기능 하락 지연. 구조 이웃이 확증 효능을 보증하지 않습니다.
SMILES
Cc1cc(=O)n(-c2ccccc2)n1Tags
Related compounds
Comparisons · briefs
External IDs · BioMoa
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.